Risk-adapted breast cancer screening and prevention most cost-effective approach in Europe.

Předmět:
Zdroj: PharmacoEconomics & Outcomes News; 8/21/2021, Vol. 885 Issue 1, p20-20, 1p
Databáze: Complementary Index